Xencor Inc. Files 2024 10-K
Ticker: XNCR · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1326732
| Field | Detail |
|---|---|
| Company | Xencor Inc (XNCR) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
Xencor filed its 2024 10-K, detailing financials and progress on its drug pipeline.
AI Summary
Xencor Inc. filed its 2024 10-K on February 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in Pasadena, CA, operates in the pharmaceutical preparations sector. The filing details its financial performance and business operations for the year, including its ongoing development of novel protein therapeutics.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of Xencor's financial health and strategic direction for the past fiscal year, crucial for understanding the company's progress in developing its therapeutic pipeline.
Risk Assessment
Risk Level: medium — As a biotechnology company, Xencor faces inherent risks related to drug development, clinical trials, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the 10-K filing.)
- 2023 — Previous Fiscal Year End (For comparison with the current fiscal year's performance.)
- 2022 — Prior Fiscal Year End (For trend analysis over multiple years.)
Key Players & Entities
- Xencor Inc. (company) — Filer of the 10-K report
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date
- Pasadena, CA (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What were Xencor's total revenues for the fiscal year ended December 31, 2024?
The provided text does not contain specific revenue figures for the fiscal year ended December 31, 2024.
What is Xencor's primary business focus as indicated by its SIC code?
Xencor Inc.'s Standard Industrial Classification (SIC) code is 2834, which corresponds to Pharmaceutical Preparations.
When was this 10-K filing submitted to the SEC?
This 10-K filing was submitted to the SEC on February 27, 2025.
Where is Xencor Inc. headquartered?
Xencor Inc. is headquartered in Pasadena, CA, with its business address listed as 465 N. Halstead St., Suite 200.
What is the SEC file number for Xencor Inc.'s 10-K filing?
The SEC file number for Xencor Inc.'s 10-K filing is 001-36182.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Xencor Inc (XNCR).